top
Search terms
Results 1 - 7 of 7 - ordered by :
Epeuropace

Death, severe stroke, acute heart failure, or severe limitations of exercise capacity in some patients contrast with frequent asymptomatic episodes of the arrhythmia in others.1113 Treatment options ...

Europace, AFNET, Paulus Kirchhof, Angelo Auricchio, Jeroen Bax, Harry Crijns, John Camm, Hans-Christoph Diener, Andreas Goette, Gerd Hindricks, Stefan Hohnloser, Lukas Kappenberger, Karl-Heinz Kuck, ...

Date : 01/11/2007 Item size : 664703 bytes
Epeuropace

Adjunctive CFAE ablation increased procedural, fluoroscopy, and RF application times, and the risk/benefit profile of adjunctive CFAE ablation deserves further evaluation with additional studies and ...

Europace, CLINICAL RESEARCH, Melissa H. Kong, Jonathan P. Piccini, Tristram D. Bahnson

Date : 01/02/2011
Epeuropace

Abstract Aims To compare clinical characteristics, procedure complexity, acute and long-term outcome of ablate and pace (A&P) with pulmonary vein isolation (PVI) in patients with drug-refractory ...

Europace, CLINICAL INVESTIGATIONS, Alessandro Proclemer, Giuseppe Allocca, Dario Gregori, Carlo Bonanno, Renato Ometto, Alessandro Fontanelli, Roberto Mantovan, Martino Crosato, Vittorio Calzolari, ...

Date : 01/09/2008
Ehjournal

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 147574 bytes
Ehjournal

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 147532 bytes
Ehjournal

Digoxin in heart failure In the past, it was assumed that the beneficial effect of digoxin in HF was due to its (positive) inotropic properties, which were more pronounced at higher doses of the ...

European Heart Journal, van Veldhuisen, Dirk J., Van Gelder, Isabelle C., Ahmed, Ali, Gheorghiade, Mihai

Date : 21/05/2013 Item size : 162594 bytes
Ehjournal

Within 6-month follow-up, the time to AF relapse increased on dronedarone 800mg, with a median of 60 days vs 5.3 days in the placebo group (relative risk reduction 55% [95% CI, 28 to 72%] ...

European Heart Journal, Touboul, Paul, Brugada, Josep, Capucci, Alessandro, Crijns, Harry J.G.M., Edvardsson, Nils, Hohnloser, Stefan H.

Date : 01/08/2003 Item size : 170622 bytes